Pay in installments of $5.49 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 17 - Jul 22
For Your Every Summer RSVP, with Code: SUMMER15
Description
Adiós a la Migraña / Goodbye MigrainesEntiende tu dolor de cabeza y descubre cmo tratarlo de la mano de uno de los neurlogos ms reconocidos de Espaa. Histricamente, la medicina ha centrado sus esfuerzos en patologas graves y potencialmente mortales. Sin embargo, hay enfermedades en apariencia inofensivas que igualmente pueden minar la vida de quien las padece. Este es el caso de las cefaleas, uno de los trastornos ms habituales del sistema nervioso. De hecho, se estima que cerca de la
Entiende tu dolor de cabeza y descubre cómo tratarlo de la mano de uno de los neurólogos más reconocidos de España.Históricamente, la medicina ha centrado sus esfuerzos en patologías graves y potencialmente mortales. Sin embargo, hay enfermedades en apariencia inofensivas que igualmente pueden minar la vida de quien las padece. Este es el caso de las cefaleas, uno de los trastornos más habituales del sistema nervioso. De hecho, se estima que cerca de la mitad de la población mundial sufre o ha sufrido dolor de cabeza en algún momento de su vida. Hay más de ciento cincuenta tipos de cefaleas, con distintas causas, formas e intensidades, y algunos de ellos, como la migraña, pueden llegar a ser del todo incapacitantes en el día a día de una persona. Por ello, es importante conocerlos, identificarlos y darles la importancia que merecen. El doctor Jesús Porta-Etessam, especialista en neurología y patologías asociadas al sistema nervioso, nos acerca las claves para enfrentarnos a ellos y mejorar nuestra calidad de vida. Y nos ayuda, al fin, a arrojar algo de luz sobre un tema que afecta a tanta gente y sobre el que aún planean tantas incógnitas. ENGLISH DESCRIPTION Understand your headaches and discover how to treat them by following the advice of one of the Spain's leading neurologists. Historically, medical science has focused its efforts on serious and potentially fatal diseases. Other health problems, however, may seem relatively minor but can still derail the lives of those who suffer them. This is true of headaches, one of the most common disorders of the nervous system. In fact, close to half of the world population is estimated to have had a headache at some point. There are more than 150 types of headaches of differing causes, symptoms and intensity. Some of them, such as migraines, can be completely incapacitating. This is why it is so important to identify them, understand them and treat them with the seriousness they deserve. Dr. Jesús Porta-Etessam, a neurologist specializing in pathologies associated with the nervous system, gives us the keys to manage headaches and improve our quality of life. In the process, he sheds much-needed light on a problem that affects so many people but about which little is known.
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.4 ★★★★★
Based on 30 reviews
Sort
Product Reviews
★★★★★ 3
Slightly repetitive but I did love some things
Format: Kindle
I love this type of story. And omegaverse is one of my all time favorite genres. But there are a few things that pulled me out of my enjoyment while I was reading. It was repetitive at times as well as struggled with telling not showing. So we didn’t always feel like we were experiencing things with the main character. There were also some plot holes but they may still be answered in part 2.
Now this isn’t to be said I didn’t enjoy parts of the story. I loved the almost instant love between Mila and Oliver. And how he started changing around her.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 15, 2024
★★★★★ 5
delightful read
Format: Kindle
What a delightful read. The characters are awesome, the plot was so good, I loved it. I was intrigued and it kept me wanting more. Told in multiple pov, the book sucks you in and doesn’t let go. I cannot wait to read the next book.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 30, 2025
★★★★★ 4
not bad
Format: Kindle
I loved the plot of this book. The characters just didn’t have a lot of depth. The connections and “love” just weren’t communicated very well in the writing. The author didn’t write the sweet psycho trope very well at all either. Lachlan was just a mess of a character.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on November 17, 2023
★★★★★ 5
A Beta Worth Rooting For
Format: Kindle
In Spare, Violet Fox flips the omegaverse on its head, giving us a Beta heroine determined to make her mark. Joining the Beta Trials to support her sick father, she's thrown into a pack that doesn't want her, especially the possessive Alphas.
But here's the twist: their sweet Omega turns out to be her scent match. Cue the angst, forbidden tension, and a slow-burn romance that will make your heart ache in the best way.
Violet Fox delivers an emotional, refreshing take on the genre, proving Betas aren't "spares." They're stars.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 10, 2025
★★★★★ 5
Beta, Alpha, Omega oh my!
Format: Kindle
Omegas are precious and given to Alphas & their packs... but the Betas want in too. To this end, the Beta government is rolling out its trial of assigning a Beta to each Alpha-Omega pack. But forcing a Beta into a pack where they are not wanted will not end well... Of course, no one expected the Omega to fall for the assigned Beta. Great read and cliffhanger
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 15, 2025